Sofosbuvir as treatment against dengue?

Dengvaxia® (CTD-TDV), the only licensed tetravalent dengue vaccine by Sanofi Pasteur, was made available since 2015. However, administration of CTD-TDV, in general, has not received the prequalification recommendation from the World Health Organization. Having a universal antidengue agent for treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: Gan, Chye Sheng, Lim, See Khai, Chee, Chin Fei, Yusof, Rohana, Heh, Choon Han
Format: Article
Published: Wiley 2017
Subjects:
Online Access:http://eprints.um.edu.my/22051/
https://doi.org/10.1111/cbdd.13091
Tags: Add Tag
No Tags, Be the first to tag this record!